By Iain Gilbert
Date: Monday 20 Jul 2026
(Sharecast News) - Drugmaker GSK said on Monday that the European Medicines Agency had accepted its submission to update the label for its Bexsero asset, allowing for a single‑dose booster in people aged 10 and over who were previously vaccinated in childhood.
GSK said that, if approved, the booster would enable...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news